Search by Drug Name or NDC

    NDC 63304-0774-10 Lorazepam 2 mg/1 Details

    Lorazepam 2 mg/1

    Lorazepam is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by SUN PHARMACEUTICAL INDUSTRIES INC. The primary component is LORAZEPAM.

    Product Information

    NDC 63304-0774
    Product ID 63304-774_b8fbb599-96d9-4866-908d-d8be424e5ee3
    Associated GPIs
    GCN Sequence Number 003759
    GCN Sequence Number Description lorazepam TABLET 2 MG ORAL
    HIC3 H20
    HIC3 Description ANTI-ANXIETY - BENZODIAZEPINES
    GCN 14162
    HICL Sequence Number 004846
    HICL Sequence Number Description LORAZEPAM
    Brand/Generic Generic
    Proprietary Name Lorazepam
    Proprietary Name Suffix n/a
    Non-Proprietary Name Lorazepam
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 2
    Active Ingredient Units mg/1
    Substance Name LORAZEPAM
    Labeler Name SUN PHARMACEUTICAL INDUSTRIES INC
    Pharmaceutical Class Benzodiazepine [EPC], Benzodiazepines [CS]
    DEA Schedule CIV
    Marketing Category ANDA
    Application Number ANDA076045
    Listing Certified Through 2024-12-31

    Package

    NDC 63304-0774-10 (63304077410)

    NDC Package Code 63304-774-10
    Billing NDC 63304077410
    Package 1000 TABLET in 1 BOTTLE (63304-774-10)
    Marketing Start Date 2023-06-25
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 0.06833
    Pricing Unit EA
    Effective Date 2024-02-21
    NDC Description LORAZEPAM 2 MG TABLET
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 1
    Classification for Rate Setting G
    As of Date 2024-02-21
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis